Tag:
Teijin Pharma
Latest Headlines
Latest Headlines
BMS offers up to $385M to develop atrial fibrillation drug
Bristol-Myers Squibb has forged a deal to pay two Japanese developers up to $385 million for the right to collaborate on a new, early-stage drug that is intended to help people who suffer from an
